Cure Alzheimer's Fund — Investigator-Initiated Grants
Funds Alzheimer research proposals across foundational and clinical stages through investigator-led routes.
Cure Alzheimer's Fund's Investigator-Initiated Grants track supports scientists studying Alzheimer's disease across foundational biology, translational work, drug discovery, and clinical development. It sits under a U.S. foundation focused on Alzheimer's research and is built for qualified investigators who bring their own ideas to the table. Applications are accepted as rolling letters of inquiry rather than through a fixed annual deadline. The program is a grant, funded projects carry a 15% indirect-cost cap, and the extracted record does not publish an award size. Eligibility is limited to nonprofit, university, and research organization applicants; for-profit companies and individuals are not eligible. The breadth of the program is its main value: it can support work at very different stages as long as the science is tied to Alzheimer's disease. It is best suited to teams with a clear hypothesis and a credible research plan, even when the financing terms are less fully disclosed than in larger, recurring award lines.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.